Business Context and Reporting Period
Company: LeMaitre Vascular, Inc. (LMAT)
Filing Type: Form 8-K (Current Report)
Date of Report: August 4, 2026
Reporting Period: Preliminary results for the quarter ended June 30, 2026.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. Consequently, the filing text does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Forward-Looking Statements: The report contains forward-looking statements based on management's preliminary expectations. These statements involve risks and uncertainties that could cause actual results to differ materially from predictions.
Risk Factors: The filing directs readers to the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K and subsequent filings for a detailed list of risks.
Disclaimer: The Company undertakes no obligation to update forward-looking statements to reflect new information or unanticipated events after the date of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, earnings, and cash flow figures for the quarter ended June 30, 2026.
- Verify the Company's most recent Form 10-K for updated risk factors referenced in this filing.
- Confirm whether the preliminary results align with any previously issued guidance.
- Check for any unusual items or contingencies detailed in the full press release text.